| 9.66 0.05 (0.52%) | 11-28 13:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 11.64 | 1-year : | 12.47 |
| Resists | First : | 9.96 | Second : | 10.68 |
| Pivot price | 9.42  |
|||
| Supports | First : | 8.81 | Second : | 7.33 |
| MAs | MA(5) : | 9.68 |
MA(20) : | 9.5 |
| MA(100) : | 9.28 |
MA(250) : | 9.39  |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 47.1 |
D(3) : | 45.8 |
| RSI | RSI(14): 54.6 |
|||
| 52-week | High : | 11.63 | Low : | 7.1 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ AHCO ] has closed below upper band by 23.9%. Bollinger Bands are 11.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 9.86 - 9.91 | 9.91 - 9.95 |
| Low: | 9.47 - 9.54 | 9.54 - 9.59 |
| Close: | 9.51 - 9.61 | 9.61 - 9.7 |
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
Sun, 23 Nov 2025
Is It Time To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)? - 富途牛牛
Mon, 17 Nov 2025
AdaptHealth (NASDAQ: AHCO) cuts term loan A by $275M, boosting S&P unsecured rating - Stock Titan
Tue, 04 Nov 2025
AdaptHealth (AHCO) Profitability Marks Turnaround, Challenging Bearish Valuation Narratives - Sahm
Tue, 04 Nov 2025
AdaptHealth (NASDAQ:AHCO) Beats Q3 Sales Expectations - TradingView
Tue, 04 Nov 2025
AdaptHealth Corp (AHCO) Q3 Earnings: EPS Meets Expectations at $ - GuruFocus
Tue, 04 Nov 2025
AdaptHealth Corp. SEC 10-Q Report - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 135 (M) |
| Shares Float | 90 (M) |
| Held by Insiders | 8.1 (%) |
| Held by Institutions | 104 (%) |
| Shares Short | 9,730 (K) |
| Shares Short P.Month | 10,350 (K) |
| EPS | 0.55 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 12.19 |
| Profit Margin | 2.5 % |
| Operating Margin | 8.1 % |
| Return on Assets (ttm) | 3.6 % |
| Return on Equity (ttm) | 5.5 % |
| Qtrly Rev. Growth | 1.7 % |
| Gross Profit (p.s.) | 5.16 |
| Sales Per Share | 24.07 |
| EBITDA (p.s.) | 4.67 |
| Qtrly Earnings Growth | 6.6 % |
| Operating Cash Flow | 569 (M) |
| Levered Free Cash Flow | 192 (M) |
| PE Ratio | 17.56 |
| PEG Ratio | 0 |
| Price to Book value | 0.79 |
| Price to Sales | 0.4 |
| Price to Cash Flow | 2.29 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|